{
  "id": 2277778,
  "title": "Ryan Fukushima, CEO, sells $2.04m in Tempus AI stock",
  "url": "https://urgent.news/2026/08/21/ryan-fukushima-ceo-sells-2-04m-in-tempus-ai-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-21T02:16:29.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ryan-fukushima-ceo-sells-204m-in-tempus-ai-stock-93CH-4870774"
  },
  "original_language": "en",
  "account": "Ryan Fukushima, CEO and Data Director of Tempus AI, sold 41,095 shares of the company's Class A Common Stock on August 18, 2026. The sale totaled approximately $2,038,722, with shares traded at prices ranging from $49.35 to $49.99, and a weighted average price of $49.61 per share. This move was to cover tax withholding obligations from the vesting of restricted stock units, as mandated by Tempus AI's equity incentive plans. Following the transactions, Fukushima directly owns 562,463 shares of Class A Common Stock, with an additional 61,706 shares indirectly held by his spouse. A ProInvesting tip suggests that TEM's stock price movements are highly volatile, with a beta of 3.58, and is currently considered overvalued based on the platform's Fair Value assessment. Tempus AI recently reported its second-quarter 2026 financial results, with revenue growing 22% year-over-year to $382.5 million. This exceeded H.C. Wainwright's projection of $390.9 million but fell short of expectations, leading the firm to lower its price target to $56 while maintaining a Buy rating. Adjusted earnings per share were negative $0.04, compared to the anticipated loss of $0.08. This represents the first full quarter since Tempus AI's acquisition of Ambry Genetics, which contributed to the revenue increase. BTIG adjusted its price target for Tempus AI to $70 from $80, while Stifel lowered its target to $50 and maintained a Hold rating. The company received xT CDx approval, expected to mitigate risks from a potential average selling price increase in 2027 and announced plans to acquire Personalis, attracting investor attention.",
  "summary": null,
  "key_points": [
    "CEO Ryan Fukushima sold $2.04m in Tempus AI stock on August 18, 2026",
    "Shares traded between $49.35 and $49.99, weighted average $49.61",
    "Fukushima retains 562,463 shares directly, 61,706 indirectly held"
  ],
  "editors_take": "The CEO's sale of $2.04m in Tempus AI stock to cover tax obligations does not directly indicate a loss of confidence in the company, but rather is a mandated transaction tied to equity incentive plans.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Crowdstrike CEO George Kurtz sells over $4.1m in company stock",
        "url": "https://urgent.news/2026/08/21/crowdstrike-ceo-george-kurtz-sells-over-4-1m-in-company-stock",
        "published": "2026-08-21T03:17:20.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}